Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OmniXan
- Development stage
- Phase 3
- Lead developer
- OmniActive Health Technologies
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
OmniXan is a naturally derived dietary supplement ingredient containing RR-zeaxanthin (3R, 3'R zeaxanthin), a specific isomer of the carotenoid zeaxanthin. Developed by OmniActive Health Technologies, it is extracted from paprika (*Capsicum annum*). OmniXan is primarily used in nutraceutical formulations to support eye health, specifically targeting the macula. As an antioxidant, it helps protect ocular tissues by absorbing high-energy blue light and scavenging free radicals, thereby potentially reducing the risk of age-related macular degeneration (AMD) and cataracts. It has achieved self-affirmed Generally Recognized as Safe (GRAS) status and is available in various delivery formats such as beadlets and oil suspensions for inclusion in supplements and functional foods.
- Brand names
- OmniXan
- Other names
- RR-zeaxanthin3R, 3'R zeaxanthinzeaxanthin
02
Targets
GSTP1 (Glutathione S-transferase P)TUBB (Tubulin (alpha and beta subunits))
Beyond the preview
Go deeper on OmniXan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OmniXan.